A method for inducing and expanding γδt cells with high killing activity in vitro

A technology of killing activity and cells, applied in the direction of animal cells, vertebrate cells, cell culture active agents, etc., to meet the needs of clinical applications, strong anti-tumor activity, and good promotion value.

Active Publication Date: 2022-03-29
吉林省吉恩致合生物治疗技术有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to solve the problem of how to expand a large number of γδT cells with high killing activity in the prior art, and to provide a method for inducing and expanding γδT cells with high killing activity in vitro

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for inducing and expanding γδt cells with high killing activity in vitro
  • A method for inducing and expanding γδt cells with high killing activity in vitro
  • A method for inducing and expanding γδt cells with high killing activity in vitro

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] A method for inducing and expanding γδT cells in vitro, comprising the steps of:

[0027] (1) Preparation of PBMCs:

[0028] A. Use heparin anticoagulated vacuum blood collection tube to extract 50mL peripheral blood from a healthy volunteer, centrifuge at 3000rpm room temperature for 10min, put the plasma into a new 50mL centrifuge tube, and place it in a constant temperature incubator at 56°C for 30min to inactivate complement.

[0029] B. Take 30mL of lymphocyte separation solution and add it evenly to the lymphocyte separation tubes, 15mL in each tube.

[0030] C. Add 40mL of PBS to the centrifuged cell pellet, mix well, slowly add the diluted blood cells into the lymphocyte separation tube containing 15mL of lymphocyte separation medium, and centrifuge at 1800rpm for 20min at room temperature.

[0031] D. After centrifugation, gently remove the buffy coat cells in the middle of the lymphocyte separation tube to two new 50mL centrifuge tubes, then add 10 times the...

Embodiment 2

[0044] A method for inducing and expanding γδT cells in vitro, comprising the steps of:

[0045] (1) Preparation of PBMCs:

[0046] A. Use a heparin anticoagulated vacuum blood collection tube to extract 50mL peripheral blood from another healthy volunteer, centrifuge at 3000rpm room temperature for 10min, put the plasma into a new 50mL centrifuge tube, and place it in a constant temperature incubator at 56°C 30min to inactivate complement.

[0047] B. Take 30mL of lymphocyte separation solution and add it evenly to the lymphocyte separation tubes, 15mL in each tube.

[0048] C. Add 40mL of PBS to the centrifuged cell pellet, mix well, slowly add the diluted blood cells into the lymphocyte separation tube containing 15mL of lymphocyte separation medium, and centrifuge at 1800rpm for 20min at room temperature.

[0049] D. After centrifugation, gently remove the buffy coat cells in the middle of the lymphocyte separation tube to two new 50mL centrifuge tubes, then add 10 times...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for inducing and expanding γδT cells in vitro, which belongs to the field of biotechnology. The method first obtains peripheral blood mononuclear cells (PBMCs) through lymphocyte separation fluid, and then utilizes serum-free medium containing zoledronic acid, IL-2, IL-7 and IL-15 to stimulate culture for 3 days; Serum-free medium containing IL-2, IL-7 and IL-15 was used for stimulation and expansion culture; when cultured to 7-9 days, Nicotinamide was added to improve the anti-tumor activity of γδT cells. The invention does not need to purify PBMCs, and can obtain γδT cells with a purity of more than 90% after 14 days of culture; the addition of nicotinamide can obviously improve the anti-tumor activity of γδT cells. The invention can expand the γδT cells by more than 1500 times, and can meet the clinical requirement for the number of γδT cells. The invention has simple operation steps, strong operability and good popularization value.

Description

technical field [0001] The invention relates to a method for inducing and expanding gamma delta T cells with high killing activity in vitro, belonging to the field of biotechnology. Background technique [0002] γδT cells are T cells that perform innate immune functions and are a type of innate immune cells, and their TCR is composed of γ and δ chains. Its TCR lacks diversity and can directly recognize some complete polypeptide antigens. The types of antigens recognized by γδT cells are limited: ① HSP; ② lipid antigens extracted from CD1 molecules on the surface of infected cells; ③ certain viral proteins or viral proteins expressed on the surface of infected cells; ④ phosphorylated antigens in bacterial lysates. Such T cells are mainly distributed in mucosal and subcutaneous tissues such as the intestinal respiratory tract and genitourinary tract, and only account for CD3 cells in peripheral blood. + 0.5%-1% of T cells, although the peripheral blood T lymphocytes are rela...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/0783
CPCC12N5/0636C12N2501/2315C12N2501/2307C12N2501/2302C12N2500/38C12N2501/06
Inventor 牛超崔久嵬李薇
Owner 吉林省吉恩致合生物治疗技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap